Bausch Health
02.22.21
Bausch Health To Reduce Debt By $100 Million Using Cash Generated From OperationsSource: Bausch Health
11.16.20
B+L: Investigational In Vitro Data Indicates Complete Inactivation Of SARS-CoV-2 With Lumify and Besivance Eye DropsSource: Bausch Health
10.15.20
Bausch Health and BHVI Announce Global Licensing Agreement For Myopia Control Contact LensSource: Bausch Health
09.24.20
Bausch Health Announces Vyzulta Now Approved in Seven Countries; Expanded Coverage in CanadaSource: Bausch Health
09.21.20
Bausch Health Acquires Option To Purchase Ophthalmology Assets Of Allegro OphthalmicsSource: Bausch Health
04.28.20
Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch HealthSource: Clearside Biomedical